Company
Modulate Bio
- Business model
- B2B
Record updated 28 September 2026
About
Modulate Bio's AI-powered discovery platform is engineered to overcome the limitations of current neurological treatments. By precisely designing novel GABAA positive allosteric modulators, the company is developing a pipeline of differentiated therapies for Essential Tremor, epilepsy, and anxiety that promise greater efficacy without the common side effects of today's standards of care.